日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Weekly Oral Prophylaxis With MK-8527 Protects Rhesus Macaques From Intrarectal Challenge With Simian-Human Immunodeficiency Virus

每周口服MK-8527进行预防可保护恒河猴免受猴-人免疫缺陷病毒直肠内感染

期刊:Journal of Infectious Diseases
影响因子:4.5
doi:10.1093/infdis/jiaf610
Diamond, Tracy L; Kapoor, Yash; Li, Fangbiao; Wan, Bang-Lin; Boddicker, Melissa A; Maxwell, Jill W; Ngo, Winnie; Fontenot, Jane A; Soileau, Kelly A; Villinger, Francois J; Grobler, Jay A; Wang, Shubing; Fillgrove, Kerry L; Lange, Henry S; Asante-Appiah, Ernest
微生物学
炎症/感染
Human
免疫/内分泌
Rhesus
发表日期：2026
文献求助 收藏

MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosing

MK-8527 是一种新型的 HIV-1 逆转录酶易位抑制剂，具有延长给药时间的潜力。

期刊:PLoS Biology
影响因子:7.2
doi:10.1371/journal.pbio.3003308
Raheem, Izzat T; Girijavallabhan, Vinay; Fillgrove, Kerry L; Goh, Shih Lin; Bahnck-Teets, Carolyn; Huang, Qian; Li, Fangbiao; Wan, Bang-Lin; O'Donnell, Gregory T; Patteson, Jonathan B; Cilento, Maria E; Bennet, Amrith; Hayes, Robert P; Tummala, Srivanya; McHale, Carolyn; Wiltsie, Judyann; Ellis, Joan; Asante-Appiah, Ernest; Hazuda, Daria J; Hale, Jeffrey; Grobler, Jay A; Xu, Min; Diamond, Tracy L; Lai, Ming-Tain
HIV
微生物学
发表日期：2025
文献求助 收藏

Effectiveness of islatravir post-exposure prophylaxis after intravenous challenge with simian immunodeficiency virus in rhesus macaques

伊斯拉曲韦在恒河猴静脉注射猴免疫缺陷病毒后进行暴露后预防的有效性

期刊:Journal of the International Aids Society
影响因子:4.9
doi:10.1002/jia2.26507
Markowitz, Martin; Gettie, Agegnehu; St Bernard, Leslie; Grasperge, Brooke; Vargo, Ryan; Pham, Michelle; Fillgrove, Kerry; Dube, Neal; Diamond, Tracy L; Hazuda, Daria J; Grobler, Jay A
微生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial

更正：来自随机、安慰剂对照 MOVe-OUT 试验的莫努匹拉韦治疗非住院 COVID-19 成年患者的病毒学结果

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-024-00947-w
Strizki, Julie M; Grobler, Jay A; Murgolo, Nicholas; Fridman, Arthur; Johnson, Matthew G; Du, Jiejun; Carmelitano, Patricia; Brown, Michelle L; Paschke, Amanda; De Anda, Carisa
微生物学
发表日期：2024
文献求助 收藏

No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavir

伊斯拉曲韦和来那卡帕韦联合用药在体外无拮抗作用或交叉耐药性，且耐药性产生屏障较高。

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00334-24
Diamond, Tracy L; Goh, Shih Lin; Ngo, Winnie; Rodriguez, Silveria; Xu, Min; Klein, Daniel J; Grobler, Jay A; Asante-Appiah, Ernest
发表日期：2024
文献求助 收藏

Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT)

COVID-19 大流行期间呼吸道病毒合并感染：来自 2/3 期 molnupiravir 试验 (MOVe-OUT) 的流行病学分析和临床结果

期刊:Microbiology Spectrum
影响因子:3.8
doi:10.1128/spectrum.03563-23
Johnson, Matthew G; Strizki, Julie M; Jensen, Erin; Cohen, Jonathan; Katlama, Christine; Fishchuk, Roman; Ponce-de-León, Alfredo; Fourie, Nyda; Cheng, Chien-Yu; McCoy, Dorothy; Vesnesky, Mary; Norice, Carmelle T; Zhang, Ying; Williams-Diaz, Angela; Brown, Michelle L; Carmelitano, Patricia; Grobler, Jay A; Paschke, Amanda; De Anda, Carisa
炎症/感染
微生物学
发表日期：2024
文献求助 收藏

Virologic Outcomes with Molnupiravir in Non-hospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial

来自随机、安慰剂对照的 MOVe-OUT 试验中，莫努匹拉韦治疗非住院 COVID-19 成年患者的病毒学结果

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-023-00891-1
Strizki, Julie M; Grobler, Jay A; Murgolo, Nicholas; Fridman, Arthur; Johnson, Matthew G; Du, Jiejun; Carmelitano, Patricia; Brown, Michelle L; Paschke, Amanda; De Anda, Carisa
微生物学
发表日期：2023
文献求助 收藏

Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial

莫努匹拉韦治疗免疫功能低下患者的 COVID-19：来自 3 期随机、安慰剂对照 MOVe-OUT 试验的疗效、安全性和病毒学结果

期刊:Infection
影响因子:3.6
doi:10.1007/s15010-022-01959-9
Johnson, Matthew G; Strizki, Julie M; Brown, Michelle L; Wan, Hong; Shamsuddin, Hala H; Ramgopal, Moti; Florescu, Diana F; Delobel, Pierre; Khaertynova, Ilsiyar; Flores, José F; Fouche, Leon F; Chang, Shan-Chwen; Williams-Diaz, Angela; Du, Jiejun; Grobler, Jay A; Paschke, Amanda; De Anda, Carisa
微生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to Resistance

多拉韦林和伊斯拉曲韦具有互补的耐药谱，二者联合使用可形成高耐药屏障。

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.02223-21
Lai, Ming-Tain; Feng, Meizhen; Xu, Min; Ngo, Winnie; Diamond, Tracy L; Hwang, Carey; Grobler, Jay A; Hazuda, Daria J; Asante-Appiah, Ernest
发表日期：2022
文献求助 收藏

Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

伊斯拉曲韦具有较高的耐药屏障，并且与已批准的核苷类逆转录酶抑制剂（NRTIs）表现出不同的耐药性特征。

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00133-22
Diamond, Tracy L; Ngo, Winnie; Xu, Min; Goh, Shih Lin; Rodriguez, Silveria; Lai, Ming-Tain; Asante-Appiah, Ernest; Grobler, Jay A
发表日期：2022
文献求助 收藏